Elite Capital
Elite Capital is a venture capital / private equity firm targeting life sciences companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Elite Capital Information
Geographic Data
Address: 2U, Block A, Guomen Building, No. 1
City: Chaoyang
State: beijing municipality
Zip: 100028
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Elite Capital is a venture capital / private equity firm targeting life sciences companies; they have both a RMB and a USD fund. Elite Capital USD Fund targets innovative U.S. medical device and biopharma companies with strong U.S. and China market opportunities. In addition to capital, Elite Capital could provide accelerated, cost-effective development of the China market. Support services include China management team recruitment, Chinese clinical trials, CFDA regulatory filing and approval guidance, strategic planning and business development. Elite Capital RMB Fund targets China domestic life sciences companies. They target both larger companies at the cusp of IPO, as well as smaller companies with strong product portfolio and great upside. In addition, the RMB fund will provide capital to incubate leading technologies and products from overseas in China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2019 | Haihe Biopharma | Series B | 0 |
| 3/2020 | ExcelMab | Series A | 1.4M |
| 1/2018 | KBP Biosciences | Series A | 0 |
| 9/2018 | Meichuang Technology | Series B | 0 |
| 7/2017 | Kuaile Zhihui | Series A | 0 |
| 3/2020 | ExcelMab | Series A | 0 |
| 2/2019 | Haihe Biopharma | Series B | 0 |
| 9/2018 | Meichuang Technology | Series B | 0 |
| 1/2018 | KBP Biosciences | Series A | 0 |
| 7/2017 | Kuaile Zhihui | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
